Abstract
Dendrimers are synthetic monodisperse polymers with a repeatedly branched, highly structured architecture adopting globular three-dimensional shape. Applications of dendrimers are very diverse. They can be used in physics, organic chemistry, biomedical applications, catalysis, and as solubilizing agents. Acridine-loaded dendrimers can serve as inhibitors of topoisomerase II and proteasome. Due to enhanced solubility and prolonged half-lives, they are superior than corresponding monomeric acridines in treatment of various cancers. Moreover, multiple presentation of acridines significantly increases biological activity of dendrimeric drugs much more than corresponds to the increase of acridine concentration. Brush-like dendrimers containing acridine units are suitable for delivery of gene across the blood–brain barrier.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Šebestík, J., Niederhafner, P., Ježek, J.: Peptide and glycopeptide dendrimers and analogous dendrimeric structures and their biomedical applications. Amino Acids 40(2), 301–370 (2011)
Šebestík, J., Reiniš, M., Ježek, J.: Biomedical Applications of Peptide-, Glyco- and Glycopeptide Dendrimers, and Analogous Dendrimeric Structures. Springer, Wien (2012). ISBN 978-3-7091-1205-2 (hard cover); ISBN 978-3-7091-1206-9 (eBook)
Chabre, Y., Roy, R.: Design and creativity in synthesis of multivalent neoglycoconjugates. Adv. Carbohydr. Chem. Biochem. 63, 165–393 (2010)
Chabre, Y., Roy, R.: Recent trends in glycodendrimer syntheses and applications. Curr. Top. Med. Chem. 8(14), 1237–1285 (2008)
Tomalia, D.: In quest of a systematic framework for unifying and defining nanoscience. J. Nanoparticle Res. 11(6), 1251–1310 (2009)
Tomalia, D.A.: Dendritic effects: dependency of dendritic nano-periodic property patterns on critical nanoscale design parameters (CNDPs). New J. Chem. 36, 264–281 (2012)
Darbre, T., Reymond, J.L.: Glycopeptide dendrimers for biomedical applications. Curr. Top. Med. Chem. 8(14), 1286–1293 (2008)
Astruc, D., Boisselier, E., Ornelas, C.: Dendrimers designed for functions: From physical, photophysical, and supramolecular properties to applications in sensing, catalysis, molecular electronics, photonics, and nanomedicine. Chem. Rev. 110(4), 1857–1959 (2010)
McCarthy, J.M., Appelhans, D., Tatzelt, J., Rogers, M.S.: Nanomedicine for prion disease treatment: new insights into the role of dendrimers. Prion 7(3), 198–202 (2013)
Tomalia, D.: Birth of a new macromolecular architecture: dendrimers as quantized building blocks for nanoscale synthetic polymer chemistry. Prog. Polym. Sci. 30(3–4), 294–324 (2005)
Svenson, S.: Dendrimers as versatile platform in drug delivery applications. Eur. J. Pharm. Biopharm. 71(3), 445–462 (2009)
Svenson, S., Chauhan, A.: Dendrimers for enhanced drug solubilization. Nanomedicine 3(5), 679–702 (2008)
Svenson, S., Tomalia, D.: Dendrimers in biomedical applications - reflections on the field. Adv. Drug Deliv. Rev. 57(15), 2106–2129 (2005)
Sourdon, V., Mazoyer, S., Pique, V., Galy, J.P.: Synthesis of new bis- and tetra-acridines. Molecules 6(8), 673–682 (2001)
Vispe, S., Vandenberghe, I., Robin, M., Annereau, J.P., Creancier, L., Pique, V., Galy, J.P., Kruczynski, A., Barret, J.M., Bailly, C.: Novel tetra-acridine derivatives as dual inhibitors of topoisomerase II and the human proteasome. Biochem. Pharmacol. 73(12), 1863–1872 (2007)
Galdino-Pitta, M.R., Pitta, M.G.R., Lima, M.C.A., Galdino, L.S., Pitta, R.I.: Niche for acridine derivatives in anticancer therapy. Mini Rev. Med. Chem. 13(9), 1256–1271 (2013)
Gamage, S.A., Spicer, J.A., Atwell, G.J., Finlay, G.J., Baguley, B.C., Denny, W.A.: Structure-activity relationships for substituted bis(acridine-4-carboxamides): a new class of anticancer agents. J. Med. Chem. 42(13), 2383–2393 (1999)
Lee, Y., Hyun, S., Kim, H.J., Yu, J.: Amphiphilic helical peptides containing two acridine moieties display picomolar affinity toward HIV-1 RRE and TAR. Angew. Chem. Int. Ed. 47(1), 134–137 (2008)
Kitamatsu, M., Kitabatake, M., Noutoshi, Y., Ohtsuki, T.: Synthesis and properties of peptide dendrimers containing fluorescent and branched amino acids. Biopolymers 100(1), 64–70 (2013)
Speight, L.C., Muthusamy, A.K., Goldberg, J.M., Warner, J.B., Wissner, R.F., Willi, T.S., Woodman, B.F., Mehl, R.A., Petersson, E.J.: Efficient synthesis and in vivo incorporation of acridon-2-ylalanine, a fluorescent amino acid for lifetime and Förster resonance energy transfer/luminescence resonance energy transfer studies. J. Am. Chem. Soc. 135(50), 18806–18814 (2013)
Ragozin, E., Redko, B., Tuchinsky, E., Rozovsky, A., Albeck, A., Grynszpan, F., Gellerman, G.: Biolabile peptidyl delivery systems toward sequential drug release. Biopolymers 106(1), 119–132 (2016)
Bongarzone, S., Bolognesi, M.L.: The concept of privileged structures in rational drug design: focus on acridine and quinoline scaffolds in neurodegenerative and protozoan diseases. Expert Opin. Drug Discov. 6(3), 251–268 (2011)
Dufès, C., Uchegbu, I., Schätzlein, A.: Dendrimers in gene delivery. Adv. Drug Deliv. Rev. 57(15), 2177–2202 (2005)
Paleos, C., Tsiourvas, D., Sideratou, Z.: Molecular engineering of dendritic polymers and their application as drug and gene delivery systems. Mol. Pharm. 4(2), 169–188 (2007)
Yellepeddi, V., Kumar, A., Palakurthi, S.: Surface modified poly(amido) amine dendrimers as diverse nanomolecules for biomedical applications. Expert Opin. Drug Deliv. 6(8), 835–850 (2009)
Hemmer, R., Hall, A., Spaulding, R., Rossow, B., Hester, M., Caroway, M., Haskamp, A., Wall, S., Bullen, H.A., Morris, C., Haik, K.L.: Analysis of biotinylated generation 4 poly(amidoamine) (PAMAM) dendrimer distribution in the rat brain and toxicity in a cellular model of the blood-brain barrier. Molecules 18(9), 11537–11552 (2013)
Fricker, G., Ott, M., Mahringer, A. (eds.): The Blood Brain Barrier (BBB). Springer, Wien (2014)
Zhang, H., Mitin, A., Vinogradov, S.V.: Efficient transfection of blood-brain barrier endothelial cells by lipoplexes and polyplexes in the presence of nuclear targeting NLS-PEG-acridine conjugates. Bioconjugate Chem. 20(1), 120–128 (2009)
Zhang, H., Gerson, T., Varney, M.L., Singh, R.K., Vinogradov, S.V.: Multifunctional peptide-PEG intercalating conjugates: programmatic of gene delivery to the blood-brain barrier. Pharm. Res. 27(12), 2528–2543 (2010)
Fernandez, C.A., Baumhover, N.J., Anderson, K., Rice, K.G.: Discovery of metabolically stabilized electronegative polyacridine-PEG peptide DNA open polyplexes. Bioconjugate Chem. 21(4), 723–730 (2010)
Kizzire, K., Khargharia, S., Rice, K.: High-affinity PEGylated polyacridine peptide polyplexes mediate potent in vivo gene expression. Gene Ther. 20(4), 407–416 (2013)
Khargharia, S., Kizzire, K., Ericson, M.D., Baumhover, N.J., Rice, K.G.: PEG length and chemical linkage controls polyacridine peptide DNA polyplex pharmacokinetics, biodistribution, metabolic stability and in vivo gene expression. J. Control. Release 170(3), 325–333 (2013)
Shiraishi, T., Hamzavi, R., Nielsen, P.: Targeted delivery of plasmid DNA into the nucleus of cells via nuclear localization signal peptide conjugated to DNA intercalating bis- and trisacridines. Bioconjugate Chem. 16(5), 1112–1116 (2005)
Niederhafner, P., Šebestík, J., Ježek, J.: Glycopeptide dendrimers part II. J. Pept. Sci. 14(1), 44–65 (2008)
Baumhover, N.J., Anderson, K., Fernandez, C.A., Rice, K.G.: Synthesis and in vitro testing of new potent polyacridine-melittin gene delivery peptides. Bioconjugate Chem. 21(1), 74–83 (2010)
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Copyright information
© 2017 Springer International Publishing AG
About this chapter
Cite this chapter
Ježek, J., Hlaváček, J., Šebestík, J. (2017). Acridine on Dendrimeric Carriers. In: Biomedical Applications of Acridines . Progress in Drug Research, vol 72. Springer, Cham. https://doi.org/10.1007/978-3-319-63953-6_9
Download citation
DOI: https://doi.org/10.1007/978-3-319-63953-6_9
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-63952-9
Online ISBN: 978-3-319-63953-6
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)